Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.49 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.49 |
| ▸ | CASP2 | P42575 | 1/20 | 0.49 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.44 |
| ▸ | SELP | P16109 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GRK2 | P25098 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15056473 | 1.00 | FAAH (0.49) | FAAHDNM1CASP2NAAAEPHX2 | |
| SCHEMBL28221663 | 0.94 | CASP2 (0.53) | FAAHDNM1CASP2NAAAEPHX2 | |
| SCHEMBL6239067 | 0.94 | CASP2 (0.53) | FAAHDNM1CASP2NAAAEPHX2 | |
| SCHEMBL16289831 | 0.94 | CASP2 (0.53) | FAAHDNM1CASP2NAAAEPHX2 | |
| SCHEMBL29411282 | 0.94 | CASP2 (0.53) | FAAHDNM1CASP2NAAAEPHX2 | |
| SCHEMBL6237083 | 0.94 | CASP2 (0.53) | FAAHDNM1CASP2NAAAEPHX2 | |
| SCHEMBL28221043 | 0.93 | CASP2 (0.54) | FAAHDNM1CASP2NAAAEPHX2 | |
| SCHEMBL12761238 | 0.93 | CASP2 (0.54) | FAAHDNM1CASP2NAAAEPHX2 | |
| Betaine SCHEMBL11160459 | 0.92 | EPHX2 (0.44) | FAAHDNM1CASP2NAAAEPHX2 | |
| SCHEMBL12134883 | 0.90 | CASP2 (0.51) | FAAHDNM1CASP2NAAAEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260108624-A1 | METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF NUCLEIC ACIDS AND OTHER MOLECULES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-04-23 | — | — | US | disclosed |
| US-12440550-B2 | Immunogenic compositions and uses thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-10-14 | — | — | US | disclosed |
| US-20250312436-A1 | STABILIZATION OF VIRUS-BASED THERAPEUTIC AGENT | ELAREX INC. (CA) | 2025-10-09 | — | — | US | disclosed |
| US-20240374703-A1 | IMMUNOGENIC COMPOSITIONS AND USES THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-11-14 | — | — | US | disclosed |
| EP-4454664-A2 | DISSOLVABLE FILMS AND METHODS OF THEIR USE | Board of Regents, The University of Texas System (US) | 2024-10-30 | — | — | EP | disclosed |
| EP-3534974-B1 | DISSOLVABLE FILMS AND METHODS OF THEIR USE | UNIV TEXAS (US) | 2024-08-21 | — | — | EP | disclosed |
| US-20240240204-A1 | METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF ADENO-ASSOCIATED VIRAL VECTOR AND OTHER MOLECULES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-07-18 | — | — | US | disclosed |
| WO-2024073362-A2 | METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF NUCLEIC ACIDS AND OTHER MOLECULES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-04-04 | — | — | WO | disclosed |
| EP-4344699-A2 | METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF NUCLEIC ACIDS AND OTHER MOLECULES | The Board of Regents of the University of Texas System (US) | 2024-04-03 | — | — | EP | disclosed |
| EP-4333896-A1 | METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF ADENO-ASSOCIATED VIRAL VECTOR AND OTHER MOLECULES | Board of Regents, The University of Texas System (US) | 2024-03-13 | — | — | EP | disclosed |
| EP-3534974-A2 | DISSOLVABLE FILMS AND METHODS OF THEIR USE | Board of Regents, The University of Texas System (US) | 2019-09-11 | — | — | EP | disclosed |
| US-10279029-B2 | Immunogenic compositions and uses thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2019-05-07 | — | — | US | disclosed |
| EP-2793819-B1 | COLOURING COMPOSITION WITH DIRECT DYES AND ZWITTERIONIC SURFACTANTS | HENKEL AG & CO KGAA (DE) | 2019-01-02 | — | — | EP | disclosed |
| US-20180326036-A1 | IMMUNOGENIC COMPOSITIONS AND USES THEREOF | UNIV TEXAS (US) | 2018-11-15 | — | — | US | disclosed |
| US-9974850-B2 | Immunogenic compositions and uses thereof | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2018-05-22 | — | — | US | disclosed |
| US-20160296616-A1 | IMMUNOGENIC COMPOSITIONS AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-10-13 | — | — | US | disclosed |
| US-9125832-B2 | Coloring composition with direct dyes and zwitterionic surfactants | HENKEL AG & CO. KGAA (DE) | 2015-09-08 | — | — | US | disclosed |
| EP-2793819-A2 | COLOURING COMPOSITION WITH DIRECT DYES AND ZWITTERIONIC SURFACTANTS | Henkel AG&Co. KGAA (DE) | 2014-10-29 | — | — | EP | disclosed |
| US-20140298595-A1 | COLORING COMPOSITION WITH DIRECT DYES AND ZWITTERIONIC SURFACTANTS | HENKEL AG & CO. KGAA (DE) | 2014-10-09 | — | — | US | disclosed |
| WO-2013092088-A2 | COLOURING COMPOSITION WITH DIRECT DYES AND ZWITTERIONIC SURFACTANTS | HENKEL AG & CO. KGAA (DE) | 2013-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140298595-A1 | COLORING COMPOSITION WITH DIRECT DYES AND ZWITTERIONIC SURFACTANTS | KRT18, DSG1, DSP | FAAH 2299/4885DNM1 706/4885CASP2 4221/4885 |
| US-20260108624-A1 | METHODS AND COMPOSITIONS FOR TRANSPORT, STORAGE, AND DELIVERY OF NUCLEIC ACIDS AND OTHER MOLECULES | SLC2A9, SLC2A2, TRMT1 | FAAH 4611/4885DNM1 2457/4885CASP2 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.